These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17277077)

  • 1. Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis.
    Urushitani M; Ezzi SA; Julien JP
    Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2495-500. PubMed ID: 17277077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS.
    Gros-Louis F; Soucy G; Larivière R; Julien JP
    J Neurochem; 2010 Jun; 113(5):1188-99. PubMed ID: 20345765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
    Turner BJ; Talbot K
    Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amyotrophic lateral sclerosis: recent insights from transgenic animal models with SOD1 mutations].
    Aoki M
    Rinsho Shinkeigaku; 2004 Nov; 44(11):788-91. PubMed ID: 15651292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
    Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
    Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit of tianeptine and morphine in a transgenic model of familial amyotrophic lateral sclerosis.
    Chritin M; Savasta M; Besson G
    Amyotroph Lateral Scler; 2006 Mar; 7(1):32-7. PubMed ID: 16546757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice.
    Chen R; Ende N
    J Med; 2000; 31(1-2):21-30. PubMed ID: 10998753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis.
    Gomes C; Keller S; Altevogt P; Costa J
    Neurosci Lett; 2007 Nov; 428(1):43-6. PubMed ID: 17942226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Implications of successful immunotherapy in ALS model mice].
    Urushitani M
    Brain Nerve; 2008 Jun; 60(6):643-51. PubMed ID: 18567360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of protective immunity by vaccination with wild-type apo superoxide dismutase 1 in mutant SOD1 transgenic mice.
    Takeuchi S; Fujiwara N; Ido A; Oono M; Takeuchi Y; Tateno M; Suzuki K; Takahashi R; Tooyama I; Taniguchi N; Julien JP; Urushitani M
    J Neuropathol Exp Neurol; 2010 Oct; 69(10):1044-56. PubMed ID: 20838241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice.
    Yan J; Xu L; Welsh AM; Chen D; Hazel T; Johe K; Koliatsos VE
    Stem Cells; 2006 Aug; 24(8):1976-85. PubMed ID: 16644922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse effects of a SOD1-peptide immunotherapy on SOD1 G93A mouse slow model of amyotrophic lateral sclerosis.
    Sábado J; Casanovas A; Rodrigo H; Arqué G; Esquerda JE
    Neuroscience; 2015 Dec; 310():38-50. PubMed ID: 26384962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of superoxide dismutase elevates reactive species: comparison of nitration and oxidation of proteins in different brain regions of transgenic mice with amyotrophic lateral sclerosis.
    Liu D; Bao F; Wen J; Liu J
    Neuroscience; 2007 Apr; 146(1):255-64. PubMed ID: 17368952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender difference in levels of Cu/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Frutiger K; Lukas TJ; Gorrie G; Ajroud-Driss S; Siddique T
    Amyotroph Lateral Scler; 2008 Jun; 9(3):184-7. PubMed ID: 18574763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of monomer/misfolded SOD1 as a therapeutic strategy for amyotrophic lateral sclerosis.
    Liu HN; Tjostheim S; Dasilva K; Taylor D; Zhao B; Rakhit R; Brown M; Chakrabartty A; McLaurin J; Robertson J
    J Neurosci; 2012 Jun; 32(26):8791-9. PubMed ID: 22745481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Animal models of amyotrophic lateral sclerosis].
    Yamanaka K
    Rinsho Shinkeigaku; 2007 Nov; 47(11):934-7. PubMed ID: 18210840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis.
    Kirkinezos IG; Hernandez D; Bradley WG; Moraes CT
    Ann Neurol; 2003 Jun; 53(6):804-7. PubMed ID: 12783429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adeno-associated virus-mediated delivery of a recombinant single-chain antibody against misfolded superoxide dismutase for treatment of amyotrophic lateral sclerosis.
    Patel P; Kriz J; Gravel M; Soucy G; Bareil C; Gravel C; Julien JP
    Mol Ther; 2014 Mar; 22(3):498-510. PubMed ID: 24394188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosis.
    Maier M; Welt T; Wirth F; Montrasio F; Preisig D; McAfoose J; Vieira FG; Kulic L; Späni C; Stehle T; Perrin S; Weber M; Hock C; Nitsch RM; Grimm J
    Sci Transl Med; 2018 Dec; 10(470):. PubMed ID: 30518612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model.
    Ralph GS; Radcliffe PA; Day DM; Carthy JM; Leroux MA; Lee DC; Wong LF; Bilsland LG; Greensmith L; Kingsman SM; Mitrophanous KA; Mazarakis ND; Azzouz M
    Nat Med; 2005 Apr; 11(4):429-33. PubMed ID: 15768029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.